Briskr and Qserve announce a new partnership

Today, Briskr and Qserve announce a new partnership whereby Qserve will provide support to Briskr start-ups and SMEs towards successful growth. Briskr is a consortium in the Nijmegen area with the aim of helping start-ups and SMEs to grow faster and make more impact on the Life Sciences & Health and High Tech sectors. Briskr believes that interaction between knowledge-intensive companies and knowledge institutes, such as universities and government institutions, is essential to realize innovation. Operating in three areas – business support, project and program development for innovation activities, and acquisition of innovation companies, Briskr brings together innovative entrepreneurs in its incubation program (start-ups), acceleration program (scale-ups), and activation program (established SMEs).

Qserve is a consultancy company operating in the worlds main medical markets. The team of experts and professionals support manufacturers worldwide to help improve patient safety and health by supporting the advancement of biomedical technology. Qserve assist medical device and in-vitro diagnostics manufacturers worldwide with market access, medical device approvals, clinical trials and achieving and maintaining regulatory compliance. 

Qserve is an important addition to the Brisk ecosystem. For many startups in healthcare certification is an important hurdle in order to enter the market. Qserve will, together with Briskr and other supporting partners, develop workshops around certification and help coach startups in relation to certification and clinical validation. With this addition we expect to further advance the startup ecosystem in the Nijmegen Area.

Martijn Kriens, program manager of Briskr: “We are happy that Qserve is willing to expand our network of services for startups. Professional support early in relation to certification and quality information is important for startups to have access to. With the partnership with Qserve we enhance the access to these.”

Martin de Bruin, Partner at Qserve Group: “Qserve is highly engaged with start-ups, bringing new devices and/or technologies to the market that improve patient safety. With the Briskr program we can help the start up community with our practical approach; to translate the existing regulations into understandable requirements.”

Look back: How2Finance

Yesterday morning we gathered early for the breakfast session on #How2Finance.
A large group of startups and entrepreneurs listened to various experts from Oost NL, Orion, Rabobank, Oneplanetcrowd, Netherlands Enterprise Agency (RVO) and Briskr who elaborated on a solid life cycle funding; Which options on financing can be used in different phases of the development of a company?
We then offered various rounds of speed dating with the experts so entrepreneurs could discuss their individual case. In the meantime we enjoyed the networking, drinks and bites.
We look back on a dynamic event with enthusiastic entrepreneurs that we can hopefully help grow their businesses in the near future.

Webinar: risk-base quality management in modern clinical trials

During your study, our Biostatisticians ensure that data is monitored centrally to identify outliers and systematic errors and enable corrective and preventive actions before data integrity is at risk. Assistance in determining the impact of decisions made during your study on the evaluation is further provided, to ensure that all collected data can be evaluated as expected. A final data review prior to the analysis further ensures that all pre-specified analyses can be conducted as desired, and necessary changes are prospectively implemented.

More information by this link. Or contact René Pulles by e-mail.

Webinar: audit and inspection readiness in clinical investigations

This webinar is intended for medical device manufacturers and all parties involved in planning and performing the clinical investigations with medical devices in EU.

The webinar provides basic information on the audit and inspection readiness in clinical investigations, including practical tips for preparation, conduct and follow-up after the audit/inspection and sharing real experiences as lessons learned from various audits and inspections.

More information by this link. Or contact René Pulles by e-mail.

Company Valuation & legal issues of joint ventures with investors

What’s the value of your company?
Valuation of a company is almost always hard. Sentiments play a role, but also the fact that there are many alternative ways to look at the value of a company. This is of course even more true if you run a start-up as the past offers little foundation to determine future performance and worth. But for all growth stages valuation is immensely important since external financing is in most cases the only way to grow. Therefore, it’s necessary that you understand how valuation works, that you know how best to prepare for negotiations and how to determine the conditions. This is what this workshop offers. It helps create a better understanding of company valuation and investment terms as well as the process to reach an investment deal.

Understanding the other site of the table
Investors and entrepreneurs both want a deal that makes them happy. In order to have fruitful discussions about the valuation of your company, it’s therefore important for both sides of the table to have a good understanding of each other’s perspective. What does an investor look for in a business case? What is expected from you as an entrepreneur? But also, what can you expect from an investor? Now during the deal making phase, but also later on as a shareholder in your company? Instead of looking for a bigger slice of the pie, the goal should be to make the pie bigger for everyone at the table. 

Legal issues regarding the participation of investors
When an investor and entrepreneur cooperate, in principle, they have the same objectives. But that’s not the case on all aspects of the cooperation. For instance regarding an exit or the relationship between the management board and the general meeting of shareholders. These are some of the most important issues in the cooperation between an entrepreneur and an investor. Thorough thought on these issues upfront contribute to a smooth cooperation between entrepreneur and an investor.

Presenters
Emile Sahar, Poelmann van den Broek Lawyers
Maurice Koopmans, Aeternus corporate finance
Bram ten Bok, Oost NL

Live event
We aim to organize this workshop in a live setting and will take all necessary RIVM/national measures into account. If a physical workshop is not possible, we will reschedule to a later date.

Good to know
We finish off with drinks & bites. This workshop is free of charge and facilitated in English. Please register upfront! 

We look forward to meet you!


The workshop is meant for investment seeking start-ups/ scale-ups; entrepreneurs that are either in or approaching the phase to find and contract investors. It is free of charge, but registration is needed. There is a maximum of 16 participants. And to prepare for this wokshop we will ask you to answer some questions in advance.

Business model Check Up

Business models aren’t valid forever. Your own direction changes over time, the world around you changes and sometimes things develop differently from what you had expected. What every company needs is a periodical check-up of its business model. Done by critical thinkers with a wealth of experience in where business models can go wrong and lead to failure. The earlier you can see the faults in you business model the better you can prepare to avoid the pitfalls. Success favours those who are prepared!

In this workshop we will lead you through a number of pitfalls of, especially digital, innovations that can effectively make you fail. In this way, we help you to avoid these pitfalls yourself and become successful. We will share examples about innovations that got stuck and how entrepreneurs got back on track. And offer advice on your situation!

We conclude with a business model check up of your idea and organisation: How strong is your organization when it comes to innovation and which developments can strengthen or undermine your idea? We combine everything we have shared to create a mini action plan for you.

A participant’s feedback from previous workshop: “I did not expect the hands-on and practical approach the workshop took, I have found it very useful and was happy that my business case could get attention.”

The workshop is given by two innovators of InnoValor, Claudia Vermeulen and Liesbeth Hijink. Afterwards, you will receive a trend book with digital trends and the tools we have worked with.

Live event
We aim to organize this workshop in a live setting and will take all necessary RIVM/national measures into account. If a physical workshop is not possible, we will reschedule to a later date.
 
Good to know
We finish off with drinks & bites. This workshop is free of charge and facilitated in English. Please register upfront! 

Fuck Up night

What better way is there than learn from the failures of experienced entrepreneurs?

About this event

The Vuk Up Night is an event to inspire entrepreneurial-minded people with real fuck up stories. During the Vuk Up Night, entrepreneurs and leaders will enter the stage to share their journey and the failures they encountered, cause in the end ‘’If you don’t have Room to Fail, you don’t have Room to Grow’’.

Speakers:

– Judith van Dam

– Jorg Rijkschroeff

– Hubert Bruls

– Han van Krieken

Please register by this link.

Webinar: Tafelgesprek ‘Arbeidscommunicatie bij pharma bedrijven’

Arbeidsmarktcommunicatie draait om de chemie tussen potentieel talent en werkgever. Maar hoe vertaal je goed werkgeverschap in employer branding? Ben je benieuwd hoe Aspen Oss, ARDENA en Bioconnection dit in de praktijk brengen? En ben je nieuwsgierig naar de adviezen van recruitment bureau Derks & Derks?

Luister dan op 5 april van 11.30 – 12.30 naar de online tafelgesprek met Dana Kalasek (HR-manager Bioconnection), Robert Dam (Plantmanager Aspen Oss), Rob Abbenhuis (BU Director ARDENA) en Tim van Loon (Head recruitment Derks & Derks). Samen met moderator Alexander Steegh en Sidekick Ria Hein zullen zij praktijkervaringen delen tijdens dit interessante tafelgesprek.

Vragen waar we graag een antwoord op krijgen:

Wat speelt er en wat doe jij om je bedrijf aantrekkelijk te laten zijn voor werknemers? Wat speelt er nu op de arbeidsmarkt? Waarom is er krapte? Wat kun je als werkgever doen om de juiste kandidaten te werven en te behouden? Hoe werven jullie nieuwe mensen?

Registratielink: https://www.lifeteczone.nl/bijeenkomst/webinar-tafelgesprek-arbeidscommunicatie-bij-pharma-bedrijven/

Bioconnection – Dana Kalasek (HR-manager)

Het farmaceutische bedrijf BioConnection vult op zeer grote schaal flacons af voor onder meer voor corona-vaccins en andere geneesmiddelen. Ze bedienen klanten van enkele flacons tot meer dan honderdduizend flacons per productie hoeveelheid en daarmee is het bedrijf in staat om klanten te ondersteunen van de klinische onderzoeksfase tot aan producties op commerciële schaal.

Dana is een HR Business Partner, met ruime stafervaring binnen verschillende organisatieonderdelen, van Productie tot Research & Development, in een multinational. Als hoofdfacilitator heeft ze in het kader van cultuurveranderingen onder andere trainingen verzorgd. Haar passie is coaching en loopbaanbegeleiding vanuit respect en vertrouwen.

Aspen Oss – Robert Dam (Plantmanager)

Aspen Oss ontwikkelt en produceert complexe, hoogwaardige Actieve Farmaceutische Ingrediënten (API’s). Dit zijn de werkzame bestanddelen in geneesmiddelen. Hun producten, zoals heparine, hormonen, peptiden en steroïden, worden verwerkt tot onder meer bloedverdunners, spierverslappers, anticonceptie en anesthesiemiddelen. Aspen Oss maakt onderdeel uit van de Aspen Pharma Group met de hoofdvestiging in Zuid-Afrika.

Robert is een energieke, toegewijde en gepassioneerde persoon en heeft de kennis en persoonlijke flair om een ​​API-fabriek voor chemische productie te leiden. Hij is verantwoordelijk voor een personeelsbestand van 270 medewerkers, waaronder operationele productieteams, plannings-, magazijn- en logistiek-, onderhouds- en betrouwbaarheids- en engineeringteams.

ARDENA – Rob Abbenhuis (BU Director)

Ardena maakt werkzame stoffen voor geneesmiddelen met Europese vestigingen met ruim 300 werknemers die helpt met de productie van geneesmiddelen, de fabricage van doseringsvormen, klinische logistiek, bioanalyse en dossierontwikkeling.

Rob wordt warm van API-procesontwikkeling en commercialisering, commerciële API- en (steriele) productie van geneesmiddelen, secundaire verpakkingen, cGMP, Lean Six Sigma, (internationaal) projectmanagement, Supply Chain en technische diensten.

Derks & Derks – Tim van Loon (Head recruitment)

Derks & Derks is al twintig jaar actief in de Life Sciences, een sector die meer dan ooit in beweging is: innovaties volgen elkaar in hoog tempo op om echte waarde te creëren voor patiënten en cliënten in sub sectoren als Farma, Medical Devices, Biotech en Food. Techniek, onderzoek en digitalisering hebben een niet meer weg te denken invloed, maar human talent zal altijd dé centrale succesfactor blijven.

Al sinds zijn afstuderen is Tim werkzaam binnen de arbeidsbemiddeling. In zijn huidige rol bij Derks & Derks brengt hij organisaties, talenten en professionals in Life Sciences en Gezondheidszorg samen.

Datum: 5 april 2022

Tijd: 11.30 – 12.30

Organisatie: Pivot Park en Lifeteczone

Podcast AI for Life #10 – Will siri soon be speaking ‘Fries’?

Speech recognition has been around for a while now and has made great strides. Think of Apple’s Siri and Amazon’s Alexa, which are used by millions of people every day. Yet speech recognition still works best when spoken clearly or in a simple or narrow specialised domain. The challenge is to take this even further, so that speech recognition also works when the circumstances are more difficult. Think for example of spoken dialect where the training possibilities of the AI are often limited by the smaller data sets. Or in cases of a speech impediment after a stroke, for example. Another new direction is the detection of emotion in speech and using this to better recognise the context of what is being said.

Within the Radboud University and Radboudumc, together with Telecats, work is being done on more advanced forms of speech recognition in which atypical speech is also better recognised. For this podcast we talk to:

  • Henk van den Heuvel (Radboud University CLST)
  • Sandra van Dulmen (Radboudumc)
  • Arjan van Hessen (Telecats)
    The podcast is moderated by Martijn Kriens (Briskr)